Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia

NCT02298075 · clinicaltrials.gov ↗

COMPLETED

Status

148

Enrollment

OTHER

Sponsor class

Conditions

Immune Thrombocytopenia

Interventions

DRUG: Eltrombopag
DRUG: Romiplostin

Sponsor

Gruppo Italiano Malattie EMatologiche dell'Adulto